GMO Crops - news, views, reports

Transgenic plants have been engineered to possess several desirable traits, such as resistance to pests, herbicides, or harsh environmental conditions, improved product shelf life, and increased nut...

DENTSPLY International to Present at the William Blair Growth Stock Conference

York, PA - June 8, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Chris Clark, President and Chief Operating Officer, is speaking at the William Blair Growth Stock Confe...

DENTSPLY International Presents at the Jefferies 2012 Global Healthcare Conference

York, PA - June 4, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Bret Wise, Chairman and Chief Executive Officer, is speaking at the Jefferies 2012 Global Healthcare Con...

DENTSPLY International to Present at the SunTrust Robinson Humphrey Annual Veterinary and Dental Conference

York, PA - May 23, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that William Jellison, Senior Vice President and Chief Financial Officer, will be speaking at the SunTrust Robin...

DENTSPLY International Inc. to Present at the 5th Annual Barrington Research Growth Conference

  York, PA - August 28, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Bret Wise, Chairman and Chief Executive Officer, will be speaking at the 5th Annual Barrington Rese...

DENTSPLY International Inc. to Present at the NASDAQ OMX 29th Investor Program in London

York, PA - November 30, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Bret Wise, Chairman and Chief Executive Officer, will be presenting at the NASDAQ OMX 29th Investor Progr...

DENTSPLY International to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

York, PA - June 4, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that William Jellison, Senior Vice President and Chief Financial Officer, will be speaking at the Goldman Sa...

DENTSPLY International Inc. to Present at the 31st Annual J.P. Morgan Healthcare Conference

York, PA - January 4, 2013 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that Bret Wise, Chairman and Chief Executive Officer, will be presenting at the 31st Annual J.P. Morgan Healthca...

DENTSPLY International Inc. to Present at the Robert W. Baird 2012 Healthcare Conference

  York, PA - August 27, 2012 - DENTSPLY International Inc. (NASDAQ-XRAY) today announced that William Jellison, Senior Vice President and Chief Financial Officer, will be speaking at the Robert...

Effects of Raw Material and Rotational Speed on the Cyclic Fatigue of ProFile Vortex Rotary Instruments.

INTRODUCTION: This in vitro study compared the cyclic fatigue resistance of ProFile Vortex rotary instruments (DENTSPLY Tulsa Dental, Tulsa, OK) made of two different raw materials: M-Wire and regular...

Determination of trace and major elemental profiles in street dust samples by fast miniaturized ultrasonic probe extraction and ICP-MS.

A simple, fast and miniaturized ultrasonic probe assisted protocol for acid extraction of trace and major elements from street dust samples, prior to final determination by ICP-MS, has been optimized...

Injection profiles in liquid chromatography II: Predicting accurate injection-profiles for computer-assisted preparative optimizations.

In computer assisted optimization of liquid chromatography it has been known for some years that it is important to use experimental injection profiles, instead of rectangular ones, in order to calcul...

Autologous transplantation in multiple myeloma with an augmented conditioning protocol.

Abstract We compared the tolerability and anti-myeloma effect of 2 conditioning regimens for auto-SCT in consecutive groups of patients. Protocol 1 was the earlier and consisted of the combination of...

Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).

Objective-To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refracto...